Growth failure in Crohn’s disease children: may the first treatment have a role?

References

• Sanderson IR, Risdon RA, Walker-Smith JA. Intractable ulcerating enterocolitis of infancy. Arch Dis Child. 1991;66:295–299.
   PubMed Web of Science ®Google Scholar
• Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol. 1994;8:83–100.
   PubMedGoogle Scholar
• Cezard JP, Touati G, Alberti C, et al. Growth in pediatric Crohn’s disease. Horm Res. 2002;58:11–15.
   PubMedGoogle Scholar
• Kleinman RE, Baldassano RN, Caplan A, et al. North American society for pediatric gastroenterology, hepatology and nutrition. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American society for pediatric gastroenterology, hepatology and nutrition. J PediatrGastroenterol Nutr. 2004;39:15–27.
   PubMed Web of Science ®Google Scholar
• Puntis J, McNeish AS, Allan RN. Long term prognosis of Crohn’s disease with onset in childhood and adolescence. Gut. 1984;25:329–336.
   PubMedGoogle Scholar
• Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn’s disease: pathogenesis and interventions. Inflamm Bowel Dis. 2007;13:620–628.
   PubMed Web of Science ®Google Scholar
• Henderson P, Hansen R, Cameron FL, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis. 2012;18:999–1005.
   PubMed Web of Science ®Google Scholar
• Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ. 1994;308:1259–1263.
   PubMed Web of Science ®Google Scholar
• Ates Y, Degertekin B, Erdil A, et al. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci. 2008;53:2215–2222.
   PubMed Web of Science ®Google Scholar
• Moran GW, Leslie FC, McLaughlin JT. Crohn’s disease affecting the small bowel is associated with reduced appetite and elevated levels of circulating gut peptides. Clin Nutr. 2013;32:404–411.
   PubMed Web of Science ®Google Scholar
• Bannerjee K, Camacho-Hübner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004;38:270–275.
   PubMed Web of Science ®Google Scholar
• Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011;24:313–326.
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997;99:643–650.
   PubMed Web of Science ®Google Scholar
• Wong SC, Macrae VE, McGrogan P, et al. The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation. J Pediatr Gastroenterol Nutr. 2006;43:144–155.
   PubMed Web of Science ®Google Scholar
• Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995–1000.
   PubMed Web of Science ®Google Scholar
• Griffiths AM. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Dig Dis. 2009;27:404–411.
   PubMed Web of Science ®Google Scholar
• Ricciuto A, Fish JR, Tomalty DE, et al. Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn’s disease and associated with decreased height. Arch Dis Child. 2018;103:319–326.
   PubMed Web of Science ®Google Scholar
• Gupta N, Lustig RH, Kohn MA, et al. Menarche in pediatric patients with Crohn’s disease. Dig Dis Sci. 2012;57:2975–2981.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581–589.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445–458.
   PubMed Web of Science ®Google Scholar
• Hyams JS. Crohn’s disease in children. Pediatr Clin North Am. 1996;43:255–277.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr. 1996;129:81–88.
   PubMed Web of Science ®Google Scholar
• IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.
   PubMed Web of Science ®Google Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Ferry G, Mandel F. Development and validation of a pediatric Chron’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.
   PubMed Web of Science ®Google Scholar
• Lambert B, Lemberg S, Seach ST, et al. Longer-term outcomes of nutritional management of Crohn’s disease in children. Dig Dis Sci. 2012;57:2171–2177.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee WY, Choi KE, et al. Effect of Infliximab ‘Top-down’ therapy on weight gain in pediatric Crohn’s disease. Indian Pediatr. 2012;49:979–982.
   PubMed Web of Science ®Google Scholar
• Cameron FL, Gerasimidis K, Papangelou A, et al. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn’s disease. Aliment Pharmacol Ther. 2013;37:622–629.
   PubMed Web of Science ®Google Scholar
• Walters TD, Kim MO, Denson LA, et al. Increased effectiveness of early therapy with anti–tumor necrosis factor-a vs an immunomodulator in children with Crohn’s disease. Gastroenterology. 2014;146:383–391.
   PubMed Web of Science ®Google Scholar
• Cohen-Dolev N, Sladek M, Hussey S, et al. Differences in outcomes over time with exclusive enteral nutrition compared with steroids in children with mild to moderate Crohn’s disease: results from the GROWTH CD study. J Crohns Colitis. 2018;12:306–3012.
   PubMed Web of Science ®Google Scholar
• Schulman JM, Pritzker L, Shaoul R. Maintenance of remission with partial enteral nutrition therapy in pediatric Crohn’s disease: A retrospective study. Can J Gastroenterol Hepatol. 2017;2017:1–7. doi: 5873158.
   PubMedGoogle Scholar
• Beattie RM, Bensten BS, Macdonald TT. Childhood Crohn’s diseaseand the efficacy of enteral diets. Nutrition. 1998;14:345–350.
   PubMed Web of Science ®Google Scholar
• European Crohn’s and Colitis Organisation. European society of pediatric gastroenterology, hepatology and nutrition. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohn’s Colitis. 2014;8:1179–1207.
   Google Scholar
• Forbes A, Escher J, Hebuterne X, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321–347.
   PubMed Web of Science ®Google Scholar
• Braegger C, Decsi T, Amil Dias J, et al. Practical approach to paediatric enteral nutrition: a comment by the ESPGHAN committee on nutrition ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2010;51:110–122.
   PubMed Web of Science ®Google Scholar